Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer 02/12/2018 INTERVENTIONAL unchanged 3,117.85 0 Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience 02/13/2018 OBSERVATIONAL unchanged 3,116.85 0 Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma 02/13/2018 INTERVENTIONAL unchanged 3,116.85 0 Identification of New Prognostic Markers for Breast Cancer. 02/19/2018 OBSERVATIONAL unchanged 3,110.85 0 Accelerated Partial Breast Irradiation Study 02/19/2018 INTERVENTIONAL unchanged 3,110.85 0 Endometrial Cancer Lymphadenectomy Trial 02/19/2018 INTERVENTIONAL unchanged 3,110.85 0 Comprehensive Lifestyle Change To Prevent Breast Cancer 02/27/2018 INTERVENTIONAL unchanged 3,102.85 0 The PREDICT Registry: 02/28/2018 OBSERVATIONAL unchanged 3,101.85 0 Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients 02/28/2018 INTERVENTIONAL unchanged 3,101.85 0 Older Breast Cancer Patients: Risk for Cognitive Decline 03/01/2018 OBSERVATIONAL unchanged 3,100.85 0 Signal TrAnsduction Pathway Activity Analysis in OVarian cancER 03/08/2018 INTERVENTIONAL unchanged 3,093.85 0 Omission of Radiation in Patients With Her-2 Positive Breast Cancer 03/09/2018 INTERVENTIONAL unchanged 3,092.85 0 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC 03/13/2018 INTERVENTIONAL unchanged 3,088.85 0 Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors 03/13/2018 INTERVENTIONAL unchanged 3,088.85 0 Individual Approach in Gynecological Cancer Brachytherapy 03/15/2018 INTERVENTIONAL unchanged 3,086.85 0 PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer 03/19/2018 INTERVENTIONAL unchanged 3,082.85 0 ASA in Prevention of Ovarian Cancer (STICs and STONEs) 03/29/2018 INTERVENTIONAL unchanged 3,072.85 0 Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy 04/03/2018 INTERVENTIONAL unchanged 3,067.85 0 Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer 04/05/2018 INTERVENTIONAL unchanged 3,065.85 0 MRI Characterization of Mammographically Detected DCIS 04/11/2018 OBSERVATIONAL unchanged 3,059.85 0 Autologous Ovarian Tissue Transplantation 04/12/2018 INTERVENTIONAL unchanged 3,058.85 0 Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction 04/25/2018 OBSERVATIONAL unchanged 3,045.85 0 LimPrOn: Limburg Pre-eclampsia Investigation 04/26/2018 INTERVENTIONAL unchanged 3,044.85 0 Maternal Smoking Cessation and Pediatric Obesity Prevention 05/02/2018 INTERVENTIONAL unchanged 3,038.85 0 Follow-up in Gynecological Cancer Survivors 05/04/2018 OBSERVATIONAL unchanged 3,036.85 0 Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer 05/08/2018 INTERVENTIONAL unchanged 3,032.85 0 A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy 05/11/2018 INTERVENTIONAL unchanged 3,029.85 0 Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery 05/14/2018 INTERVENTIONAL unchanged 3,026.85 0 RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy 05/14/2018 INTERVENTIONAL unchanged 3,026.85 0 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer 05/16/2018 INTERVENTIONAL unchanged 3,024.85 0 Gestational Diabetes and Pharmacotherapy (GAP) 05/17/2018 INTERVENTIONAL unchanged 3,023.85 0 Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma 05/22/2018 INTERVENTIONAL unchanged 3,018.85 0 Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread 05/23/2018 INTERVENTIONAL unchanged 3,017.85 0 Ultrasound Identification Automation Study 05/24/2018 OBSERVATIONAL unchanged 3,016.85 0 IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry 05/25/2018 OBSERVATIONAL unchanged 3,015.85 0 The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons 05/29/2018 OBSERVATIONAL unchanged 3,011.85 0 Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer 06/06/2018 INTERVENTIONAL unchanged 3,003.85 0 Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants 06/06/2018 INTERVENTIONAL unchanged 3,003.85 0 Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort 06/14/2018 OBSERVATIONAL unchanged 2,995.85 0 A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies 06/15/2018 INTERVENTIONAL unchanged 2,994.85 0 Acupuncture and Integrative Care in Gynecological Surgery 06/18/2018 INTERVENTIONAL unchanged 2,991.85 0 Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients 06/18/2018 INTERVENTIONAL unchanged 2,991.85 0 A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients 06/19/2018 OBSERVATIONAL unchanged 2,990.85 0 Birth Cohort Study of China Medical University 06/19/2018 OBSERVATIONAL unchanged 2,990.85 0 GammaPod Registry and Quality of Life Nomogram 06/19/2018 OBSERVATIONAL unchanged 2,990.85 0 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers 06/20/2018 INTERVENTIONAL unchanged 2,989.85 0 Gynecologic Extramammary Paget's Disease 06/20/2018 OBSERVATIONAL unchanged 2,989.85 0 Vaginal Microbiome Exposure and Immune Responses in C-section Infants 06/26/2018 INTERVENTIONAL unchanged 2,983.85 0 CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer 06/26/2018 INTERVENTIONAL unchanged 2,983.85 0 Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging 06/26/2018 OBSERVATIONAL unchanged 2,983.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology